Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL)
Clinical trial NCT01530048 · COMPLETED
Trial details
- NCT number
- NCT01530048
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2006-05-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.